Plus Therapeutics Inc (NASDAQ:PSTV) price on Thursday, June 12, rose 5.82% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.35.
A look at the stock’s price movement, the close in the last trading session was $0.33. Turning to its 52-week performance, $2.33 and $0.24 were the 52-week high and 52-week low respectively. Overall, PSTV moved -49.97% over the past month.
Plus Therapeutics Inc’s market cap currently stands at around $11.43 million, with investors looking forward to this quarter’s earnings report slated for in July.
The average forecast suggests down to a -18.88% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 4.61M, representing a -20.81% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PSTV is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
PSTV’s current price about 2.87% and -38.47% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 42.04, while 7-day volatility ratio is 5.77% and 10.05% in the 30-day chart. Further, Plus Therapeutics Inc (PSTV) has a beta value of 0.63, and an average true range (ATR) of 0.08.
If we refocus on Plus Therapeutics Inc (NASDAQ:PSTV), historical trading data shows that trading volumes averaged 12.82 million over the past 3 months. The company’s latest data on shares outstanding shows there are 32.72 million shares.
The 8.87% of Plus Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 4.89% of the company’s shares. Current price change has pushed the stock -69.63% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PSTV stock continues to rise going into the next quarter.
